Result: Risk Minimisation Materials for medicines starting with the letter K
Kadcyla
Roche Products Limited

Kadcyla (trastuzumab emtansine) EU Healthcare Professional Information - Prevention of medication errors
This material is provided by Roche Products Ltd as a licence requirement for this medicine and forms part of the Risk Management Plan. Please register or log in to view the materials.
For Healthcare Professionals
Kanuma
Alexion Pharma UK Ltd

Kanuma: A Guide For Healthcare Professionals
Please read this guide carefully and use it when prescribing KANUMA® as it contains essential safety and efficacy information. The guide was created as part of the KANUMA® Risk Management Plan and includes risk-minimising measures for the safe and effective use of this medicinal product. The guide is a mandatory part of the approval process for KANUMA®, to help ensure that healthcare professionals take into account the special safety requirements of prescribing this medicinal product.
For Healthcare Professionals
Keppra
UCB Pharma Limited

DHCP Keppra Oral solution
Dear Healthcare Professional Communication related to risk of medication errors associated with overdose for Keppra Oral solution.
For Healthcare Professionals
Ketoprofen
Pinewood Healthcare

Checklist for the prescriber
Checklist for the prescriber: Minimising the risk of photosensitivity with topical ketoprofen
For Healthcare Professionals

Information sheet for patients
Information sheet for patients: Minimising the risk of skin reactions with topical ketoprofen
Kevzara
Sanofi Genzyme

Kevzara (sarilumab)- Patient Alert card-Risk Minimisation Information for Patients
This patient alert card contains important safety information that you need to be aware of before, during, and after treatment with KEVZARA For hard copies of this information please contact medical information department on 0800 035 2525 or email [email protected] .
Keytruda
Merck Sharp & Dohme (UK) Limited

Explanatory note on update to Risk Minimisation Materials
Short description of latest update of the Keytruda Materials

Patient Alert Card
The risk minimisation materials for pembrolizumab were developed as a condition of the marketing authorisation grant for this product. The patient alert card should be issued to and carried by patients being treated with pembrolizumab and provides important safety information to minimise the risk of immune-related adverse reactions. In addition it contains emergency contact details for the patient and their specialist,

Patient Information Brochure
The risk minimisation materials for pembrolizumab were developed as a condition of the Marketing Authorisation grant for this product. This brochure is for patients and will explain some of the side effects that might occur during or after treatment with pembrolizumab, and how to check for them.
Kineret
Swedish Orphan Biovitrum Ltd

Kineret Patient Booklet
The material above is available for Kineret when used in the treatment of Cryopyrin-Associated Periodic Syndromes (CAPS), Familial Mediterrranean Fever (FMF) and Still’s disease, including Systemic Juvenile Idiopathic Arthritis (SJIA) and Adult-Onset Still’s Disease (AOSD).

Kineret Patient Card
Patient reminder card to be used by patients with Still's disease.

Using Kineret. A Guide for Healthcare Professionals
The material above is available for Kineret when used in the treatment of Cryopyrin-Associated Periodic Syndromes (CAPS), Familial Mediterranean Fever (FMF) and Still’s disease, including Systemic Juvenile Idiopathic Arthritis (SJIA) and Adult-Onset Still’s Disease (AOSD).
For Healthcare Professionals
Kivexa
ViiV Healthcare UK Ltd

Abacavir Hypersensitivity Slide Deck for Healthcare Professionals
Abacavir Hypersensitivity Slide Deck for Healthcare Professionals
For Healthcare Professionals

Abacavir Hypersensitivity Website for Healthcare Professionals
Abacavir Hypersensitivity Website for Healthcare Professionals
For Healthcare Professionals
Kyleena
Bayer plc

Bayer Intrauterine System (IUS) Educational Pack
Healthcare professional brochure to describe risk of ectopic pregnancy and how to differentiate between Bayer levonorgestrel IUS (LNG-IUS)
For Healthcare Professionals
Kymriah
Novartis Pharmaceuticals UK Ltd

Kymriah HCP training
Training on risks and management of CRS and neurological events, patient education and adverse event reporting
For Healthcare Professionals


Kymriah Patient Educational Leaflet
Information for patients and caregivers

Kymriah Pharmacy Training
Pharmacy / Cell Lab / Infusion centre training material on steps for reception, storage, handling and preparation for infusion
For Healthcare Professionals